Fourth, in the review by Nono Nankam, obesity was not always linked to RBP4 levels or insulin resistance [23], and the authors concluded that the association between RBP4 levels and insulin resistance might reflect pathologies other than obesity, such as adverse fat distribution, adipose tissue dysfunction, dyslipidemia, and others. Here, RBP4 is linked to metabolic syndrome.